Key result
Down syndrome linked to ~9% APOE34 frequency, mirroring rates in healthy septuagenarians.
Why the study?
Down syndrome is considered a model for unsuccessful and early aging, possibly accelerated in APOE4 allele carriers associated with age-related diseases and poor prognosis after myocardial infarction.
Observational (n=467)
Answers are grounded in this paper and cite their sources.
DS APOE4 frequencies may refine aging models; leaves open whether they alter post-MI prognosis or warrant testing.
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerated for those who carry the APOE4 allele associated with common age-related diseases, e.g., Alzheimer's disease and a poor prognosis after acute myocardial infarction, causing lower ApoE4 frequencies among the very old in general populations. We compared ApoE genotypic frequencies found for healthy adults (n = 211, age < 40; n = 79, ages 70-79; n = 71, ages > 90) to those found for DS patients (n = 106, mean age 9 years), all living in western Sicily. We found that the frequency of the ApoE23 genotype increased with age among the healthy adults (8.5%, 6.4%, 19.7%; p = 0.024) while ApoE34 frequency decreased (16.1%, 12.6%, 4.1%; p = 0.012). DS patients had APOE34 genotypic frequencies very similar to those found in septuagenarians (9%; p = 0.005). Analyzing results according to surviving rate of persons with DS, an age-related reduction of ApoE3/4 genotype frequency was found comparing =5 years old to >5 years old DS subjects. These results highlight DS as a model to understand the role of APOE4 allele in unsuccessful ageing considering that a number of proinflammatory supernumerary genes (Cu/Zn superoxide dismutase, Ets-2 transcription factors, Down syndrome critical region 1, stress-inducible factor, interferon-alpha receptor and the amyloid precursor protein) are located on chromosome 21 and are implied in the pathologic processes of DS.
No takes yet. Share an insight, caveat, or question.
Forte et al. (2007) conducted an observational in Down syndrome (n=467). Down syndrome vs. Healthy adults was evaluated on APOE34 genotypic frequency (p=0.005). Down syndrome patients (mean age 9 years) exhibited an APOE34 genotypic frequency of 9%, similar to healthy septuagenarians, implying early unsuccessful aging for ApoE4 carriers.
Synapse has enriched 10 related papers. Consider them for comparative context: